Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells. (Q40272602)
Jump to navigation
Jump to search
scientific article published on June 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells. |
scientific article published on June 2006 |
Statements
Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells (English)
Jin T E Lim
Andrew K Joe
Masumi Suzui
Masahito Shimizu
I Bernard Weinstein